Shilpa Medicare Ltd
NSE:SHILPAMED

Watchlist Manager
Shilpa Medicare Ltd Logo
Shilpa Medicare Ltd
NSE:SHILPAMED
Watchlist
Price: 318.3 INR 0.41% Market Closed
Market Cap: 62.3B INR

SHILPAMED's latest stock split occurred on Oct 3, 2025

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, SHILPAMED traded at 389.38 per share. Afterward, the share price was about 384.95.

The adjusted shares began trading on Oct 3, 2025. This was SHILPAMED's 5th stock split, following the previous one in Sep 26, 2025.

Last Splits:
Oct 3, 2025
2-for-1
Sep 26, 2025
2-for-1
Nov 6, 2015
2-for-1
Jul 16, 2013
3-for-2
Sep 28, 2007
10-for-2
Pre-Split Price
389.38 389.38
Post-Split Price
384.95
Before
After
Last Splits:
Oct 3, 2025
2-for-1
Sep 26, 2025
2-for-1
Nov 6, 2015
2-for-1
Jul 16, 2013
3-for-2
Sep 28, 2007
10-for-2

Shilpa Medicare Ltd
Stock Splits History

SHILPAMED Stock Splits Timeline
Oct 3, 2025
Oct 3, 2025
Split 2-for-1
x2
Pre-Split Price
389.38 389.38
Post-Split Price
384.95
Before
After
Sep 26, 2025
Sep 26, 2025
Split 2-for-1
x2
Pre-Split Price
396.35 792.7
Post-Split Price
385.92
Before
After
Nov 6, 2015
Nov 6, 2015
Split 2-for-1
x2
Pre-Split Price
156.065 945.8
Post-Split Price
155.702
Before
After
Jul 16, 2013
Jul 16, 2013
Split 3-for-2
x1.5
Pre-Split Price
30.5027 279.42
Post-Split Price
30.9612
Before
After
Sep 28, 2007
Sep 28, 2007
Split 10-for-2
x5
Pre-Split Price
N/A
Post-Split Price
21.0444
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.14 0.14 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.47 8.47 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Jan 6, 2026
Itochu Corp
F:IOC0
10-for-1
x10
1060 106 EUR 10.9 10.9 EUR
Load More

Shilpa Medicare Ltd
Glance View

Market Cap
62.3B INR
Industry
Pharmaceuticals

Shilpa Medicare Ltd. engages in the manufacturing of pharmaceutical product and wind power generation. The company is headquartered in Raichur, Karnataka. The firm is engaged in manufacturing active pharmaceutical ingredients (APIs), formulation and development service. The company is focused on new drug delivery systems, peptides/biotech products and specialty chemicals. The Company’s product range include oncology and non-oncology APIs, oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. The company supplies oncology/non-oncology APIs and intermediates. Its oncology APIs products include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India.

SHILPAMED Intrinsic Value
624.55 INR
Undervaluation 49%
Intrinsic Value
Price
Back to Top